Investors in Iot

In a nutshell, Commercialization Reactor is a platform with a mission to commercialize science via a specific paradigm: Bring Scientists and Entrepreneurs together to co-create Deep-Tech startup aimed to commercialize the Core Competence of the Scientific Team. The Entrepreneurs become responsible to fulfill business leadership-related activities, taking into a full-time focus and Scientists focus exclusively on their core competence and inhale their knowledge and skills into a product or service that Entrepreneurial Team sets as a vector for business development strategy. This paradigm of commercialization together with over 10 years of experience in creating, pre-incubating and accelerating startups currently resulted in over 100 fully-formed Science-based startup companies born in CR. Most of those received investments are from various venture funds across the globe. Ultimately, this leads to unique Science-based startup creation and performance scoring methodology that is a core know-how of Commercialization Reactor. The methodology is proven successful by a fact of an exit, which already is in the arsenal of achievements of the CR Team.

Kvanted is an early-stage venture capital fund investing in Northern European companies with industry-changing software and hardware solutions. Our investment philosophy is rooted in accelerating industrial decarbonization and digital transformation, driven by powerful tailwinds from increased demand for industrial automation, sustainability, and supply chain resilience. As the next Industrial Revolution introduces new growth possibilities through groundbreaking technologies, we recognize the innovation potential of traditional European industries.

We back growth-stage ventures in verticals including esports, e-commerce, biotech, artificial intelligence, robotics and technology hardware. We also make private market investments into companies with a clear path toward an imminent IPO.

Paladin Capital Group is a leading global investor that supports and grows the world’s most innovative companies through venture investment, expansion, and growth capital. We are headquartered in Washington, DC, with offices in London, Luxembourg, New York City, and Silicon Valley. We seek out diverse investment opportunities across the US and worldwide. Paladin is a leader in investing in technologies, products, and services focused on dual use in both commercial and governmental markets with a strong value-add culture. Paladin Cyber Fund: Our most recent fund focuses on Digital Infrastructure Resilience, investing globally in advanced technologies and solutions which enable, monitor, manage, and defend critical infrastructure that is dependent on cyber space. The Fund is actively investing and has closed eleven investments.

We aim to build and nurture a portfolio of high-potential startups in the mobility space that can scale and become our closest partners to help us create better and more competitive products and services.

Thesis - digitization of European industry picks up further and on-going shortage of qualified labor drives need for solutions that replace labor. Invest Focus: Industrial Tech/B2B, IoT, Supply Chain Tech, Enterprise SaaS, HW enabled SaaS KnowHow. Countries: CZ, PL, AT, DE, SK

Deep-tech founders solving fundamental problems in clean robotics, industrial IoT, autonomous systems, and sustainable manufacturing. Particularly interested in technologies bridging physical and digital worlds—precision GPS for autonomous vehicles, AI-powered workflow automation, advanced materials, edge computing. I back companies requiring 7-10 year development timelines with patient capital.

Netherlands-based deeptech and life sciences investor.

The first investor and supporting partner to scale tech startups, ranked the no.1 accelerator linked to the University by UBI Global. Committed to supporting digital innovation and entrepreneurship in Belgium, the imec.istart business acceleration program supports entrepreneurs during the early development phase of their tech startup. This incubation takes a minimum of 12 months and is meant to assess the feasibility of the business proof-of-concept, prepare the (commercial) launch of the first product(s) and establish the startup to drive this commercialization together with the imec.istart corporate partners.

Birk Venture is a company based in Oslo, Norway, dedicated to transforming unique innovations and technologies into successful businesses in the healthcare sector. They focus on leveraging cutting-edge technologies in life science to meet the increasin.

Columbus is a Spanish investment management company that focuses on generating high returns through the Columbus Innvierte Life Science fund. This fund targets seed-stage investments in established private companies within the healthcare and life sciences sectors. The company boasts a robust investment team with international experience and a proven track record in identifying innovative excellence originating from Spanish academic institutions. COLUMBUS VENTURE PARTNERS, SGEIC, SA leverages its expertise in company building and financing to accelerate commercialization for its portfolio companies. Additionally, it facilitates rapid access to the vibrant UK and Boston/Cambridge biotech/pharma venture capital R&D ecosystem.

CRB is a private venture capital management firm dedicated to health technologies. Founded by a seasoned multi-disciplinary executive team, CRB has successfully launched three prior funds focusing on Biotech (Fund I), Medtech (Fund II), and Digital Health (Fund Nuubo). Currently, CRB is advancing with Fund III (CRB Digital Health III), which specializes in digital health. This fund is supported by a team with extensive experience spanning startups, scaleups, corporates, and public health institutions. Headquartered in Madrid and Barcelona, CRB strategically positions itself with access to Europe's most innovative hubs.